Bacillus thuringiensis (Bt) is a Gram-positive and soil-dwelling bacterium and well known for its ability to produce insecticidal parasporal crystalline protein inclusions, which have attracted worldwide interest for effective pest management. A diseased silkworm by Bt was first discovered by Japanese scientist Ishiwata Shigetane in 1901, and in 10 years, it was re-discovered in Germany by Ernst Berliner, who isolated it as the cause of a disease called Schlaffsucht in flour moth caterpillars. The first commercial product, Bt. kurstaki HD-1 was released to a market in France in 1938. Optimization of mass production for crystal production and cost down enabled the industrialization to be successful, and now many products, such as WP, EC, SC and tablets are used worldwide. In 1976 Robert A. Zakharyan found that plasmids in Bt are involved in the production of crystal proteins and endospores. Pore formation model and signal transduction model were revealed to explain the mode of action of Bt. Works on Bt resistance included a group of receptors of crystal proteins, such as cadherin, APN and ALP. In 1996, a Bt cry gene was integrated to cotton, which successfully reached markets. AtMT technology was used to generate Bt crops. Now the area planted worldwide to genetically engineered Bt crops increased to 66 million hectares. Refuge may be particularly important in slowing the spread of insects resistant to the Bt insecticides. Researchers are trying to increase the insecticidal efficacy of integrated Bt crystal proteins using recent biotechnology.